Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Washington |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00573183 |
The purpose of this study is to determine whether a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.
Condition | Intervention | Phase |
---|---|---|
Stimulant Abuse or Dependence |
Behavioral: Twelve Step Facilitation (TSF) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study |
Official Title: | Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement |
Estimated Enrollment: | 400 |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | August 2010 |
Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
STAGE-12: Experimental |
Behavioral: Twelve Step Facilitation (TSF)
The STAGE-12 intervention will consist of a combination of five group and three individual sessions. The five group sessions will be taken from the Project MATCH Twelve Step Facilitation manual as modified for use with drug abusers and adapted for delivery in a group format. The group sessions will be augmented by three individual sessions derived from the introductory and termination sessions from the TSF manual and incorporating elements of the brief intensive 12-step referral procedure.
|
Treatment as Usual: No Intervention |
This protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. Secondary objectives include evaluating reduction in percent days of use of other substances, the degree to which STAGE-12 increases involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12 -step involvement and meeting attendance mediate substance use outcomes.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Anthony Floyd, Ph.D. | 206-543-1285 | asfloyd@u.washington.edu |
United States, Florida | |
Gateway Community Services | Recruiting |
Jacksonville, Florida, United States, 32211 | |
Contact: Christine Neuenfeldt 904-721-9958 cneuenfeldt@gatewaycommunity.com | |
United States, Hawaii | |
Hina Mauka Kaneohe Rehabilitation Services | Recruiting |
Kaneohe, Hawaii, United States, 96744 | |
Contact: Nicole Baumhofer 808-236-2600 nbaumhofer@hinamauka.org | |
United States, Ohio | |
Maryhaven, Inc. | Recruiting |
Columbus, Ohio, United States, 43207 | |
Contact: Jessica Rich 614-324-5430 jrich@maryhaven.com | |
United States, Oregon | |
ChangePoint, Inc. | Recruiting |
Portland, Oregon, United States, 97233 | |
Contact: Chris Botero 503-419-2659 cbotero@changepointinc.com | |
Willamette Family Treatment Services | Recruiting |
Eugene, Oregon, United States, 97402 | |
Contact: Davina Jones 541-343-2993 davinaj@wfts.org | |
United States, Pennsylvania | |
Addiction Medicine Services (WPIC) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 | |
Contact: Mary Elyse Kaye 412-246-6467 kayeme@upmc.edu | |
United States, South Carolina | |
Dorchester Alcohol and Drug Commission | Recruiting |
Summerville, South Carolina, United States, 29483 | |
Contact: Ashley Morrill 843-871-4790 asfloyd@u.washington.edu | |
United States, Texas | |
Nexus Recovery Center | Recruiting |
Dallas, Texas, United States, 75228 | |
Contact: Aubrey Hopkins 817-569-4278 aubrey.hopkins@utsouthwestern.edu | |
United States, Washington | |
Recovery Centers of King County | Recruiting |
Seattle, Washington, United States, 98122 | |
Contact: Jessica DiCenzo 206-568-8227 jdicenzo@rckc.org | |
Evergreen Manor, Inc. | Recruiting |
Everett, Washington, United States, 98134 | |
Contact: Danielle Shandera 425-493-5320 dshandera@evergreenmanor.org |
Principal Investigator: | Dennis Donovan, Ph.D. | University of Washington |
Principal Investigator: | Dennis Daley, Ph.D. | Western Psychiatric Institute and Clinic |
Responsible Party: | University of Washington ( Dennis Donovan ) |
Study ID Numbers: | NIDA-CTN-0031, U10 DA13714 |
Study First Received: | December 13, 2007 |
Last Updated: | January 28, 2009 |
ClinicalTrials.gov Identifier: | NCT00573183 |
Health Authority: | United States: Federal Government |